These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1707840)

  • 1. [The prognostic significance of tumor cell detection in bone marrow of patients with breast cancer].
    Diel IJ; Kaufmann M; Costa SD; Kaul S; Krempien B; Goerner R; Bastert G
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):923-8. PubMed ID: 1707840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunocytochemical detection of tumor cells in bone marrow as a prognostic factor in breast carcinoma].
    Merkle E; Bähr J; Henke A; Bühner M; Martus P
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):662-9. PubMed ID: 7531659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of tumor cells in bone marrow: a deciding aid for adjuvant therapy in node negative patients with breast cancer. Concept for a multicenter study and results of the pilot phase].
    Funke I; Fries S; Jauch KW
    Chirurg; 1991 Nov; 62(11):805-9. PubMed ID: 1769261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.
    Wiedswang G; Borgen E; Kåresen R; Kvalheim G; Nesland JM; Qvist H; Schlichting E; Sauer T; Janbu J; Harbitz T; Naume B
    J Clin Oncol; 2003 Sep; 21(18):3469-78. PubMed ID: 12972522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome.
    Wiedswang G; Borgen E; Kåresen R; Qvist H; Janbu J; Kvalheim G; Nesland JM; Naume B
    Clin Cancer Res; 2004 Aug; 10(16):5342-8. PubMed ID: 15328170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunocytochemical detection and prognostic significance of epithelial tumor cells in bone marrow of patients with pancreatic carcinoma].
    Thorban S; Roder JD; Pantel K; Siewert JR
    Zentralbl Chir; 1996; 121(6):487-9; discussion 490-2. PubMed ID: 8767337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer.
    Pantel K; Izbicki JR; Angstwurm M; Braun S; Passlick B; Karg O; Thetter O; Riethmüller G
    Cancer Res; 1993 Mar; 53(5):1027-31. PubMed ID: 7679945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence.
    Janni W; Rack B; Schindlbeck C; Strobl B; Rjosk D; Braun S; Sommer H; Pantel K; Gerber B; Friese K
    Cancer; 2005 Mar; 103(5):884-91. PubMed ID: 15666325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and prognostic value of cytokeratin positive tumor cells in bone marrow of patients with renal cell carcinoma.
    Buchner A; Riesenberg R; Kotter I; Crispin A; Hofstetter A; Oberneder R
    J Urol; 2003 Nov; 170(5):1747-51. PubMed ID: 14532768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolated tumor cells in bone marrow predicts reduced survival in lymph node-negative non-small-cell lung cancer].
    Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
    Pneumologie; 2000 Aug; 54(8):355-60. PubMed ID: 11008478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow and sentinel lymph node biopsy in patients with breast cancer: from staging to ultrastaging?
    Fortunato L; Baldi A; Farina M; Campioni M; Amini M; Piro FR; Costarelli L; Pompili P; Vitelli CE
    J Exp Clin Cancer Res; 2006 Dec; 25(4):487-93. PubMed ID: 17310838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time independence of the prognostic impact of tumor cell detection in the bone marrow of primary breast cancer patients.
    Solomayer EF; Diel IJ; Salanti G; Hahn M; Gollan C; Schütz F; Bastert G
    Clin Cancer Res; 2001 Dec; 7(12):4102-8. PubMed ID: 11751508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
    Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
    J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.
    Langer I; Guller U; Koechli OR; Berclaz G; Singer G; Schaer G; Fehr MK; Hess T; Oertli D; Bronz L; Schnarwyler B; Wight E; Uehlinger U; Infanger E; Burger D; Zuber M;
    Ann Surg Oncol; 2007 Jun; 14(6):1896-903. PubMed ID: 17356955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].
    Juhl H; Kalthoff H; Krüger U; Schott A; Schreiber HW; Henne-Bruns D; Kremer B
    Chirurg; 1994 Dec; 65(12):1111-5. PubMed ID: 7851144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the immunocytochemical detection of epithelial cells in bone marrow (micrometastasis) influence the time to biochemical relapse after radical prostatectomy?
    Weckermann D; Wawroschek F; Krawczak G; Haude KH; Harzmann R
    Urol Res; 1999 Oct; 27(5):285-90. PubMed ID: 10644227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
    Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
    Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.